Barbara Morgan is Global Vice-President, Pharma and Biotechnology at Kerry. Prior to that she worked at LLS Health (part of Lubrizol) from 2014 until 2021, and was named General Manager in 2018.

With a PhD in Organic Chemistry from the University of Pennsylvania (US), Dr Morgan has more than 15 years’ experience in both drug development and business development in the pharma industry. She has published numerous articles in peer-reviewed journals and holds patents, including one on the treatment of cancer stem cells.